Zea Biosciences

Executive Summary

Zea Biosciences is a San Diego-based biotech founded in 2018, dedicated to developing novel biologic therapies for autoimmune and inflammatory diseases. The company targets significant unmet medical needs by leveraging innovative approaches in immunology and biologics. While still in early stages without disclosed pipeline details, Zea's focus on high-value therapeutic areas positions it for potential growth if it can advance candidates into clinical development. The company's lean profile suggests a need for strategic partnerships or financing to progress its programs.

Upcoming Catalysts (preview)

• Q4 2026Lead Program IND Filing40% success
• Q2 2026Series A Financing Announcement50% success
• Q3 2026Preclinical Data Presentation at Major Conference60% success